P-stalk ribosomes act as master regulators of cytokine-mediated processes.

P-stalk T cells cytokines melanoma ribosome

Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
14 Oct 2024
Historique:
received: 24 10 2023
revised: 16 08 2024
accepted: 26 09 2024
medline: 23 10 2024
pubmed: 23 10 2024
entrez: 22 10 2024
Statut: aheadofprint

Résumé

Inflammatory cytokines are pivotal to immune responses. Upon cytokine exposure, cells enter an "alert state" that enhances their visibility to the immune system. Here, we identified an alert-state subpopulation of ribosomes defined by the presence of the P-stalk. We show that P-stalk ribosomes (PSRs) are formed in response to cytokines linked to tumor immunity, and this is at least partially mediated by P-stalk phosphorylation. PSRs are involved in the preferential translation of mRNAs vital for the cytokine response via the more efficient translation of transmembrane domains of receptor molecules involved in cytokine-mediated processes. Importantly, loss of the PSR inhibits CD8+ T cell recognition and killing, and inhibitory cytokines like transforming growth factor β (TGF-β) hinder PSR formation, suggesting that the PSR is a central regulatory hub upon which multiple signals converge. Thus, the PSR is an essential mediator of the cellular rewiring that occurs following cytokine exposure via the translational regulation of this process.

Identifiants

pubmed: 39437780
pii: S0092-8674(24)01139-5
doi: 10.1016/j.cell.2024.09.039
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Anna Dopler (A)

Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Ferhat Alkan (F)

Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Yuval Malka (Y)

Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Rob van der Kammen (R)

Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Kelly Hoefakker (K)

Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Daniel Taranto (D)

Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Naz Kocabay (N)

Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Iris Mimpen (I)

Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Christel Ramirez (C)

Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Elke Malzer (E)

Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Olga I Isaeva (OI)

Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Mandy Kerkhoff (M)

Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Anastasia Gangaev (A)

Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Joana Silva (J)

Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Sofia Ramalho (S)

Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Liesbeth Hoekman (L)

Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Maarten Altelaar (M)

Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Roderick Beijersbergen (R)

Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Leila Akkari (L)

Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Jonathan Wilson Yewdell (JW)

Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Pia Kvistborg (P)

Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

William James Faller (WJ)

Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: w.faller@nki.nl.

Classifications MeSH